EXECUTIVE ENGAGEMENTS
POOL
3707
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
667
Interactions with Platform & by Email
PARTICIPANTS
111
Unique # Participated
VALIDATIONS
32
Responses Validated*
COMPANIES
79
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
192
PAGES
472
EDITION
17
PRICE
USD 5600
CODE
MCP-7635
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What`s New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Global ADME-Toxicology Testing Market to Reach $12.3 Billion by 2027
In the changed post COVID-19 business landscape, the global market for ADME-Toxicology Testing estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$12.3 Billion by 2027, growing at a CAGR of 10.9% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to record a 13.4% CAGR and reach US$5.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the High Throughput Screening segment is readjusted to a revised 7.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 15.4% CAGR
The ADME-Toxicology Testing market in the U.S. is estimated at US$3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$966.9 Million by the year 2027 trailing a CAGR of 15.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 12.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.3% CAGR.Molecular Imaging Segment to Record 9.6% CAGR
In the global Molecular Imaging segment, USA, Canada, Japan, China and Europe will drive the 9.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$974.7 Million in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
SELECT PLAYERS
Agilent Technologies, Inc.; Beckman Coulter, Inc.; BioreclamationIVT, LLC; CompuDrug International, Inc.; Cyprotex PLC.; Eurofins ADME BIOANALYSES SAS; Molecular Discovery Ltd.; MultiCASE, Inc.; PerkinElmer, Inc.; Pharmaron, Inc.; Promega Corporation; Simulations Plus, Inc.; Taconic Biosciences, Inc.; Takara Bio Europe AB; Tecan Group Ltd.; Thermo Fisher Scientific, Inc.
SEGMENTS
» Technology (Cell Culture, High Throughput Screening, Molecular Imaging, OMICS, Other Technologies) » Method (Cellular Assay, Biochemical Assay, Ex-Vivo, In Silica) » Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Latin America » Middle East » Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| ADME-Toxicology Testing – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| ADME-Tox : An Introduction |
| A Prelude to ADME Toxicology Testing |
| Impact of Covid-19 and a Looming Global Recession |
| 2020 Marked as a Year of Disruption & Transformation |
| As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021 |
| EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022 |
| COVID-19 IMPACT ON ADME TOXICOLOGY TESTING MARKET |
| Global Market Prospects and Growth Drivers |
| Drug Makers Bet on ADME & Toxicology Testing to Improve Success Rate for Potential Drug Candidates |
| Cell Culture Holds a Major Share of the Market |
| North America and Europe Dominate, Asia-Pacific Witnesses Rapid Growth |
| Competition |
| Recent Market Activity |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Increased Need to Check Late-Stage Drug Failures Drive Market Growth |
| Exhibit: Steady Increase in Average Drug Development Cost and Efforts to Mitigate Late-Stage Drug Failure Rates Highlights the Role of ADME-Toxicology Testing: Average Cost of Drug Development (in US$ Billion) in the US since 1980s |
| Impact of ADME-Tox Screening on New Drug Discovery |
| TABLE 1: Phase-I Clinical Trial Failures Before and After the Advent of Preclinical ADME/Pharmacokinetics |
| EXHIBIT: actors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others |
| EXHIBIT: Drug Withdrawals Due to Toxicity Issues (1990-early 2010s): Percentage Share Breakdown of Number of Drugs Withdrawn Due to Cardiotoxicity, Hepatotoxicity and Others |
| Pharma Industry Renews Focus on Cost Optimization |
| EXHIBIT: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2011 through 2020 |
| EXHIBIT: New FDA Approvals (2010-2020): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals |
| China and India: Hot Spots for R&D Investment |
| EXHIBIT: World R&D Market by Geographic Region (2020): Percentage Breakdown of R&D Spending for Asia, Europe, Middle East & Africa, North America and South America |
| Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge |
| Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis |
| EXHIBIT: Global Cell-based Assays Market by Segment (2020): Percentage Share Breakdown of Value Sales for Consumables, Instruments, Software, and Services |
| EXHIBIT: Global Market for Cell-based Assays by End-User (2020): Percentage Share Breakdown of Value Sales for Pharma & Biotech Companies, Government & Academic Institutes, CROs, and Others |
| EXHIBIT: World Cell-based Assays Market by Application (2020): Percentage Breakdown of Revenue for ADME, Basic Research and Drug Discovery |
| Major Types of Cell-Based HTS Assays for Drug Screening |
| Cell-based Assays in HTS and UHTS |
| Innovation in Screening Guarantees Success for Drug Discovery Programs |
| High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays |
| High Content Screening - Key Application Areas |
| HCS Market Ripe with Growth Opportunity |
| HCS vs. HTS |
| Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing |
| 3D Cell Culture Technology to Put a New Spin on In Vitro Cell Analyses |
| CDER’s DARS 2—Microphysiological 3D Cell Culture Platforms as Drug Development Tools |
| Rising Investment in Proteomics R&D Drive Cell-based Assays Market |
| Automated Multiplexing Platforms Present Growth Opportunities |
| Automation of Cell-based Assays: A Growing Trend |
| In-Silico ADME Emerge as Compelling Drug Discovery & Development Tool |
| Advantages of Using In Silico Approaches |
| Personalized Treatments & Computational Tools: Intriguing Facets of ADME R&D ADME Pharmacogenomics to Power Personalized Treatments |
| ADME Research & Emerging Computational Tools |
| Omics Technology |
| Adoption of Omics-based Technologies |
| In Vitro 3D Organoid Models to Meet ADME-Toxicity Testing Needs |
| Limitations of Traditional in vitro Cellular Models |
| Organoids Technology—Advanced in vitro 3D Platforms for More Physiologically Relevant Modeling |
| Stem Cells Exude Great Potential in Drug Toxicity Testing |
| Global Market for Stem Cell-Assays |
| Functional Assays: An Effective Way of Predicting Specific Toxic Effects |
| GPCR Targets to Drive Growth in Functional Cell Assay Market |
| Molecular Imaging and ADME |
| Organ-on-a-Chip Technology Gains Momentum in ADME Toxicology Testing |
| Technological Advancements in ADME Toxicology Testing |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for High Throughput Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Molecular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for OMICS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cellular Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biochemical Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ex-Vivo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for In Silica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Systemic Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Renal Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hepatotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Neurotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| JAPAN |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| CHINA |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| EUROPE |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 |
| FRANCE |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| GERMANY |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| UNITED KINGDOM |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| ASIA-PACIFIC |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| LATIN AMERICA |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
| Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| MIDDLE EAST |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E) |
| Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| AFRICA |
| ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E) |
| Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2012, 2021 & 2027 |
| Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2012, 2021 & 2027 |
| Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2012, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com